MARIO RODRIGUEZ: Open Payments
NPI 1316296957 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 39 payments from 11 companies in 2025. Trend: 2023 $486 · 2024 $561 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $314 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $220 |
| Tandem Diabetes Care, Inc. | 4 | $80 |
| Insulet Corporation | 2 | $79 |
| Sequel Med Tech, LLC | 3 | $66 |
| Abbott Laboratories | 2 | $40 |
| Medtronic, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
Products named: JARDIANCE, Rybelsus, Wegovy, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Omnipod, TWIIST, TRICLIP.
Industry payments across FL — which companies pay providers there.
